CAB39
Calcium-binding protein 39
Also known as: CAB39_HUMAN, CGI-66, MO25
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y376
- Gene
- CAB39
- Ensembl
- ENSG00000135932
- Chromosome
- 2
- Canonical length
- 341 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles
OverviewNCBI Gene
Enables kinase binding activity and protein serine/threonine kinase activator activity. Involved in intracellular signal transduction; peptidyl-serine phosphorylation; and positive regulation of protein phosphorylation. Located in cytoplasm. Part of serine/threonine protein kinase complex. Implicated in hepatocellular carcinoma. Biomarker of hepatocellular carcinoma and pancreatic cancer. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>Q9Y376|CAB39
1 MPFPFGKSHK SPADIVKNLK ESMAVLEKQD ISDKKAEKAT EEVSKNLVAM KEILYGTNEK
61 EPQTEAVAQL AQELYNSGLL STLVADLQLI DFEGKKDVAQ IFNNILRRQI GTRTPTVEYI
121 CTQQNILFML LKGYESPEIA LNCGIMLREC IRHEPLAKII LWSEQFYDFF RYVEMSTFDI
181 ASDAFATFKD LLTRHKLLSA EFLEQHYDRF FSEYEKLLHS ENYVTKRQSL KLLGELLLDR
241 HNFTIMTKYI SKPENLKLMM NLLRDKSRNI QFEAFHVFKV FVANPNKTQP ILDILLKNQA
301 KLIEFLSKFQ NDRTEDEQFN DEKTYLVKQI RDLKRPAQQE ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAB39 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 168 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 168 nTPM
- tongue: 111 nTPM
- tonsil: 53 nTPM
- lymph node: 52 nTPM
- esophagus: 50 nTPM
- kidney: 50 nTPM
Single-cell type
- neutrophils: 1,324 nCPM
- neutrophil progenitors: 720 nCPM
- urothelial cells: 540 nCPM
- renal collecting duct intercalated cells: 447 nCPM
- myonuclei: 379 nCPM
- monocytes: 339 nCPM
Immune cell
- neutrophil: 10 nTPM
- NK-cell: 8.5 nTPM
- naive CD8 T-cell: 6.5 nTPM
- T-reg: 6.2 nTPM
- memory CD8 T-cell: 6 nTPM
- eosinophil: 5.8 nTPM
Brain region
- white matter: 75 nTPM
- cerebral cortex: 69 nTPM
- pons: 68 nTPM
- medulla oblongata: 66 nTPM
- spinal cord: 65 nTPM
- midbrain: 65 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 2.38
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular hypotonic response
- intracellular signal transduction
- negative regulation of potassium ion transmembrane transport
- response to activity
- response to thyroid hormone
- signal transduction
Molecular functions
- kinase binding
- protein kinase activator activity
- protein serine/threonine kinase activator activity
- protein serine/threonine kinase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CAB39 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAB39 as an antibody target. Whether an autoantibody or antibody against CAB39 could matter depends on whether native CAB39 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAB39 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAB39 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...